AKORN FDA Approval ANDA 209934

ANDA 209934

AKORN

FDA Drug Application

Application #209934

Application Sponsors

ANDA 209934AKORN

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INTRAVENOUS500MG/5ML (100MG/ML)0LEVETIRACETAMLEVETIRACETAM

FDA Submissions

UNKNOWN; ORIG1AP2018-05-04STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

AKORN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209934
            [companyName] => AKORN
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVETIRACETAM","activeIngredients":"LEVETIRACETAM","strength":"500MG\/5ML (100MG\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/04\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-05-04
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.